These days big pharma has outsourced all their early stage development to startups, purchasing compounds in the late stages through acquisition. They do pay for research, but it's not going to look that way on their balance sheet.
Their primary function, as you say, is shifting far towards the marketing end.
Re:Yahoo Crosses The Line
by abecedarius on Tuesday March 13, 2012 @04:18PM
(#3700201)
I think you mean 17?
Big pharma uses patents to protect their monopoly on a drug for seven(?) years after its introduced. Once that window is up, generics come in and take a huge chunk of sales. Pharma uses marketing and advertising to push their new drugs to try to sell as many during the patent window as they possibly can, when they have a large markup on it.